Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Melanoma 15 Carcinoma, Basal Cell 6 Skin Neoplasms 5 Recurrence 2 Neoplasm Metastasis 2 Uveal Melanoma 1 Neoplasms 1 Lentigo Maligna Melanoma (Head or Neck) 1 Eyelid Squamous Cell Carcinoma 1 Eye Neoplasms 1 Eye Diseases 1 Death 1 Carcinoma, Squamous Cell 1 Carcinoma, Merkel Cell 1 Advanced Head and Neck Squamous Cell Carcinoma 1

Interventions

Ipilimumab 29 Nivolumab 23 pembrolizumab 14 incomplete Freund's adjuvant 10 Cyclophosphamide 10 Melphalan 9 Interleukin-2 9 CTLA-4 Antigen 8 tebentafusp 7 sargramostim 7 Temozolomide 7 MART-1 Antigen 7 Dacarbazine 7 Ranibizumab 6 montanide ISA 51 5 fludarabine phosphate 5 fludarabine 5 Sunitinib 5 Radiosurgery 5 Carboplatin 5 Blood Specimen Collection 5 Bevacizumab 5 aldesleukin 4 aflibercept 4 Surveys and Questionnaires 4 Magnetic Resonance Spectroscopy 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 Biopsy 4 trametinib 3 sotrastaurin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Uveal Melanoma × Surgical Procedures, Operative × Dermatologic × Clear all

NCT05402059 2022-06-15

ISABELLA

MelanomaPRO, Russia

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡